Summary & Overview
HCPCS M1501: Pathology MIPS Value Pathway
HCPCS Level II code M1501 designates services linked to the Pathology MIPS value pathway, reflecting performance measurement and reporting activities specific to pathology practice. Nationally, MIPS value pathways are central to Medicare’s shift toward value-based payment and quality reporting, making codes like M1501 relevant for pathology laboratories and clinical pathology services participating in MIPS. This code matters as stakeholders align clinical workflows and reporting infrastructure to meet pathway-specific measures and avoid negative payment adjustments.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what M1501 represents, the typical site of service, and the context for its use within value-based reporting. The publication covers benchmarks and policy context related to MIPS value pathways, implications for pathology service lines, and what payers commonly consider when evaluating pathway-aligned services. The content highlights national policy relevance, payer coverage considerations, and operational contexts for pathology laboratories integrating MIPS reporting.
Billing Code Overview
HCPCS Level II code M1501 denotes a Pathology MIPS value pathway. This code represents services associated with the Pathology track within the Merit-based Incentive Payment System (MIPS) value pathway framework. The service type is pathology services and quality/performance reporting activities tied to MIPS value pathways.
Typical site of service: pathology laboratories and clinical laboratory settings.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A pathology MIPS value pathway report is generated for a patient undergoing surgical resection of a suspicious lesion followed by laboratory pathology interpretation and reporting. A typical scenario: a 62-year-old patient undergoes an excisional biopsy of a skin lesion in an outpatient surgical clinic. The specimen is submitted to the pathology laboratory for gross examination, histologic processing, staining (including immunohistochemistry if indicated), microscopic interpretation, and a final signed pathology report. The clinical workflow includes specimen accessioning, gross description by a pathologist or pathology assistant, tissue processing by histology technicians, slide interpretation by a board-certified pathologist, generation of a synoptic report with standardized data elements for MIPS reporting, and electronic transmission of the final pathology report to the ordering clinician. The report documents diagnosis, tumor staging or margin status if applicable, ancillary test results, and discrete quality measures required by the Pathology MIPS value pathway. Patient follow-up may include multidisciplinary discussion and further treatment decisions guided by the pathology findings.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation portion of a pathology service. |